Production of low-avidity antibody by infants after infection with serogroup B meningococci.

Production of low-avidity antibody by infants after infection with serogroup B meningococci.

Experimental serogroup B meningococcal vaccines have induced only poor immune responses and have had little protective efficacy in children younger than 1 year of age. We used ELISA with potassium thiocyanate to compare the average avidity of antibody produced by infants with that of children older...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Pollard, A, Levin, M
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	2000

Míreanna comhchosúla

Seroprevalence of bactericidal antibodies against serogroup B and C Meningococci in a University Hospital
de réir: C.A.C. Gioia, et al.

Serum Bactericidal Antibody Responses of Adults Immunized with the MenB-4C Vaccine Against Genetically Diverse Serogroup B Meningococci
de réir: Giuntini, S, et al.
Foilsithe / Cruthaithe: (2016)

Cross-reactivity of 4CMenB vaccine-induced antibodies against meningococci belonging to non-B serogroups in Italy
de réir: Cecilia Fazio, et al.
Foilsithe / Cruthaithe: (2021-07-01)

Meningococci of Serogroup X Clonal Complex 181 in Refugee Camps, Italy
de réir: Paola Stefanelli, et al.
Foilsithe / Cruthaithe: (2017-05-01)

Serogroup C meningococci in Italy in the era of conjugate menC vaccination
de réir: Neri Arianna, et al.
Foilsithe / Cruthaithe: (2009-08-01)

Cluster of Serogroup W135 Meningococci, Southeastern Florida, 2008–2009
de réir: Timothy J. Doyle, et al.
Foilsithe / Cruthaithe: (2010-01-01)

FHbp variants among meningococci of serogroup B in Italy: Evolution and selective pressure, 2014-2017.
de réir: Alessandra Lo Presti, et al.
Foilsithe / Cruthaithe: (2023-01-01)

FHbp variants among meningococci of serogroup B in Italy: Evolution and selective pressure, 2014–2017
de réir: Alessandra Lo Presti, et al.
Foilsithe / Cruthaithe: (2023-01-01)

Disease susceptibility to ST11 complex meningococci bearing serogroup C or W135 polysaccharide capsules, North America
de réir: Pollard, A, et al.
Foilsithe / Cruthaithe: (2004)

Disease susceptibility to ST11 complex meningococci bearing serogroup C or W135 polysaccharide capsules, North America.
de réir: Pollard, A, et al.
Foilsithe / Cruthaithe: (2004)

Distribution of Serogroups of Neisseria meningitidis and Antigenic Characterization of Serogroup Y Meningococci in Canada, January 1, 1999 to June 30, 2001
de réir: Raymond SW Tsang, et al.
Foilsithe / Cruthaithe: (2002-01-01)

Disease Susceptibility to ST11 Complex Meningococci Bearing Serogroup C or W135 Polysaccharide Capsules, North America
de réir: Andrew J. Pollard, et al.
Foilsithe / Cruthaithe: (2004-10-01)

Frequent capsule switching in 'ultra-virulent' meningococci - are we ready for a serogroup B ST-11 complex outbreak?
de réir: Lucidarme, J, et al.
Foilsithe / Cruthaithe: (2017)

Changes in serogroup and genotype prevalence among carried meningococci in the United Kingdom during vaccine implementation.
de réir: Ibarz-Pavón, AB, et al.
Foilsithe / Cruthaithe: (2011)

Changes in Serogroup and Genotype Prevalence Among Carried Meningococci in the United Kingdom During Vaccine Implementation
de réir: Ibarz-Pavon, AB, et al.
Foilsithe / Cruthaithe: (2011)

Impact of mandatory vaccination against serogroup C meningococci in targeted and non-targeted populations in France
de réir: Samy Taha, et al.
Foilsithe / Cruthaithe: (2022-06-01)

Clonal analysis of meningococci during a 26 year period prior to the introduction of meningococcal serogroup C vaccines.
de réir: Christopher B Sullivan, et al.
Foilsithe / Cruthaithe: (2015-01-01)

Opa protein repertoires of disease-causing and carried meningococci
de réir: Callaghan, M, et al.
Foilsithe / Cruthaithe: (2008)

Opa protein repertoires of disease-causing and carried meningococci
de réir: Callaghan, M, et al.
Foilsithe / Cruthaithe: (2008)

Effectiveness of a mass immunization campaign against serogroup C meningococci in children in the Federal State of Santa Catarina, Brazil
de réir: Emil Kupek, et al.

Retraction: Clonal Analysis of Meningococci during a 26 Year Period Prior to the Introduction of Meningococcal Serogroup C Vaccines.
Foilsithe / Cruthaithe: (2015-01-01)

Effectiveness of a mass immunization campaign against serogroup C meningococci in children in the Federal State of Santa Catarina, Brazil
de réir: Kupek Emil, et al.
Foilsithe / Cruthaithe: (2001-01-01)

Age dependence of in vitro survival of meningococci in whole blood during childhood.
de réir: Ison, C, et al.
Foilsithe / Cruthaithe: (2003)

Anti-polyribosylribitol phosphate antibody concentrations and avidities in children since the start of Haemophilus influenzae type b immunization of infants in the United Kingdom.
de réir: Kelly, D, et al.
Foilsithe / Cruthaithe: (2009)

Antibody avidity to pertussis toxin after acellular pertussis vaccination and infection
de réir: Aapo Knuutila, et al.
Foilsithe / Cruthaithe: (2023-12-01)

Invasive infections due to group a streptococci and meningococci
de réir: Jesús Ruiz-Contreras
Foilsithe / Cruthaithe: (2019-11-01)

The beginning of the end for serogroup B meningococcus?
de réir: Snape, MD, et al.
Foilsithe / Cruthaithe: (2013)

The beginning of the end for serogroup B meningococcus?
de réir: Snape, MD, et al.
Foilsithe / Cruthaithe: (2013)

Avidity of serogroup A meningococcal IgG antibodies after immunization with different doses of a tetravalent A/C/Y/W135 polysaccharide vaccine.
de réir: Bårnes, G, et al.
Foilsithe / Cruthaithe: (2011)

Serogroup B meningococcal vaccines-an unfinished story.
de réir: Sadarangani, M, et al.
Foilsithe / Cruthaithe: (2010)

Clinical and economic estimation of children’s pharmacotherapy with meningococcial infections in Ukraine
de réir: Iryna Bilyk, et al.
Foilsithe / Cruthaithe: (2019-12-01)

Penicillin Dalam Pengobatan Infeksi Meningococci
de réir: Perpustakaan UGM, i-lib
Foilsithe / Cruthaithe: (1974)

Potential of recombinant opa proteins as vaccine candidates against hyperinvasive meningococci.
de réir: Callaghan, M, et al.
Foilsithe / Cruthaithe: (2011)

Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster dose
de réir: Snape, M, et al.
Foilsithe / Cruthaithe: (2013)

Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster dose.
de réir: Snape, MD, et al.
Foilsithe / Cruthaithe: (2013)

A tool for evaluating heterogeneity in avidity of polyclonal antibodies
de réir: Li, K, et al.
Foilsithe / Cruthaithe: (2023)

Towards an improved serogroup B Neisseria meningitidis vaccine.
de réir: Perrett, K, et al.
Foilsithe / Cruthaithe: (2005)

Longitudinal antibody titer, avidity, and neutralizing responses after SARS-CoV-2 infection
de réir: Jonathon M. Monroe, et al.
Foilsithe / Cruthaithe: (2022-11-01)

The Susceptibility of Meningococci to the Antimicrobial Agents in Moscow 2006 - 2015
de réir: M. A. Koroleva, et al.
Foilsithe / Cruthaithe: (2016-06-01)

Persistence of bactericidal antibodies following infant serogroup B meningococcal immunization (4CMenB) and booster dose response at 12, 18 or 24 months of age
de réir: Snape, M, et al.
Foilsithe / Cruthaithe: (2015)